Latest News and Press Releases
Want to stay updated on the latest news?
-
Dublin, March 14, 2025 (GLOBE NEWSWIRE) -- The "U.S. Cervical Cancer Laboratory Testing Market: Focus on Test Type, and Region-Level Analysis - Analysis and Forecast, 2025-2035" report has been...
-
Dublin, Dec. 10, 2024 (GLOBE NEWSWIRE) -- The "Cervical Cancer Treatment - A Global Market Overview" report has been added to ResearchAndMarkets.com's offering.The global market for Cervical Cancer...
-
Dublin, April 19, 2024 (GLOBE NEWSWIRE) -- The "HPV Associated Disorders Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The global HPV associated disorders...
-
Dublin, Oct. 16, 2023 (GLOBE NEWSWIRE) -- The "Cervical Intraepithelial Neoplasia - Pipeline Insight, 2023" clinical trials has been added to ResearchAndMarkets.com's offering. The "Cervical...
-
Dublin, Aug. 25, 2023 (GLOBE NEWSWIRE) -- The "Human Papilloma Virus Market Size by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast to...
-
Dublin, July 03, 2023 (GLOBE NEWSWIRE) -- The "Global CIN & HR-HPV Treatment Market Forecast to 2028 - Analysis by Disease Type, Strain Type, Offering, Product Type, and End-user" report has...
-
PARIS and TOULOUSE, France, June 15, 2016 (GLOBE NEWSWIRE) -- Genticel (Euronext Paris & Brussels: FR00011790542 – GTCL), a clinical-stage biotechnology company and developer of innovative...
-
PARIS and TOULOUSE, France, Jan. 07, 2016 (GLOBE NEWSWIRE) -- Genticel (Euronext Paris & Brussels: FR00011790542 – GTCL), a clinical-stage biotechnology company and developer of innovative...